
Antimalarial drug based on Berkeley technology shipped to Africa
08/13/14 Berkeley Lab — The road from lab bench to market can be long, but UC Berkeley's Jay Keasling has been patient. Thirteen years after he discovered how to make an antimalarial drug in microbes, the product - the world's first semisynthetic antimalarial drug - has been shipped from Italy to Africa to bolster the fight against this killer disease.